RARA and ductal breast carcinoma in situ: ANXA8 upregulation in different DCIS contexts may be due to either genetic mutations affecting RA-RARA transcriptional function as shown in this study, but also to epigenetic factors like RA-regulated ANXA8 regulatory miRNAs.